http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#Head http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#assertion http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#provenance http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#pubinfo http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#assertion http://purl.obolibrary.org/obo/MONDO_0002009 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0002009 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB00422 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association http://www.w3.org/2000/01/rdf-schema#label Psychostimulants were associated with statistically significant improvement in depressive symptoms in major depressive disorder (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.13-1.78; P = 0.003) and bipolar disorder (OR, 1.42; 95% CI, 1.13-1.78; P = 0.003). Efficacy outcomes differed across the psychostimulants evaluated as a function of response rates: ar/modafinil (OR, 1.47; 95% CI, 1.20-1.81; P = 0.0002); dextroamphetamine (OR, 7.11; 95% CI, 1.09-46.44; P = 0.04); lisdexamfetamine dimesylate (OR, 1.21; 95% CI, 0.94-1.56; P = ns); methylphenidate (OR, 1.49; 95% CI, 0.88-2.54; P = ns). http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#cohort http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28590365/ http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#cohort http://www.w3.org/2000/01/rdf-schema#label Adults http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort https://go.drugbank.com/drugs/DB00422 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#provenance http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#pubinfo http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#sig http://purl.org/nanopub/x/hasSignature gyElNs/op7975gNwf5i/puEX+/y1XMBea8kheaZeM774xQ/l7K/yIm4y+idSrciC0vuaqXNzQP3apaVFEbeT2x89OpQHBOUDRUJ/+ota/lQUaJzT/rI5eT136zz9iCxUWL2uXl5iKHR9UcxF3dDN/7ABpjPQwFMy26wmfwwntXI= http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://purl.org/dc/terms/created 2021-05-26T17:13:03.398+02:00 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAUxHCcirCAFpuc7XMEODs-KLvJAaYNJkMX9Gn7REUcv4 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg